tirzepatide supply FDA says this weight loss drug shortage is over, but patients worry about cost and availability FDA says years-long tirzepatide shortage

Patients who built strong protein-focused nutrition habits and a consistent exercise routine tend to maintain significantly more of their weight loss than those who relied on the medication alone

doi: 10.1038/s41575-019-0144-8 189 LassaillyGCaiazzoRBuobDPigeyreMVerkindtHLabreucheJet al

Current evidence does not confirm a direct causal link, though mood changes are being monitored as a potential rare side effect

Novo Nordisk Fair Value Estimate: $80.00 Morningstar Rating: 2 stars Morningstar Economic Moat Rating: Wide Morningstar Uncertainty Rating: High Were raising our fair value estimate of Novo Nordisk to $80 from $70 after updating our long-term GLP-1 model to include wider use and greater adherence

If you've previously been prescribed Ozempic for weight loss by another provider, consider discussing FDA-approved options such as those mentioned earlier

Exact contents vary by pharmacy, so read the label rather than the name